Evidence mapPaperPMID 41103759Full record

SynthesisFrontiers in microbiology2025

Beyond just correlation: causal machine learning for the microbiome, from prediction to health policy with econometric tools.

Issam Khelfaoui, Wenxin Wang, Hicham Meskher, Akram Ismael Shehata, Mohammed F El Basuini, Mohamed F Abouelenein, Houssem Eddine Degha, Mayada Alhoshy, Islam I Teiba, Seedahmed S Mahmoud

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Issam KhelfaouiSchool of Public Health, Shantou University/Institute of Local Government Development, Shantou University, Shantou, China.
Wenxin WangSchool of Public Health, Shantou University/Institute of Local Government Development, Shantou University, Shantou, China.
Hicham MeskherKey Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province, Department of Chemistry, Shantou University, Shantou, China.
Akram Ismael ShehataInstitute of Marine Sciences, Shantou University, Shantou, China.
Mohammed F El BasuiniKing Salman International University, El Tor, Egypt.
Mohamed F AboueleneinDepartment of Insurance and Risk Management, College of Business, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Houssem Eddine DeghaDepartment of Computer Science and Information Technologies, Faculty of New Technologies of Information and Communication, Kasdi Merbah Ouargla University, Ouargla, Algeria.
Mayada AlhoshyIndependent Researcher, Alexandria, Egypt.
Islam I TeibaDepartment of Botany, Faculty of Agriculture, Tanta University, Tanta, Egypt.
Seedahmed S MahmoudDepartment of Biomedical Engineering, College of Engineering, Shantou University, Shantou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human microbiome is increasingly recognized as a key mediator of health and disease, yet translating microbial associations into actionable interventions remains challenging. This review synthesizes advances in machine learning (ML) and causal inference applied to human microbiome research, emphasizing policy-relevant applications. Explainable ML approaches, have identified microbial drivers, guiding targeted strategies. Econometric tools, including instrumental variables, difference-in-differences, and panel data models, provide robust frameworks for validating causal relationships, while hybrid methods like Double Machine Learning (Double ML) and Deep Instrumental Variables (Deep IV) address high-dimensional and non-linear effects, enabling precise evaluation of microbiome-mediated interventions. Policy translation is further enhanced by federated learning, standardized analytical pipelines, and model visualization frameworks, which collectively improve reproducibility, scalability, and data privacy compliance. By integrating predictive power with causal rigor, microbiome research can move beyond observational associations to generate interventions that are biologically grounded, clinically actionable, and policy-ready. This roadmap provides a blueprint for translating mechanistic microbial insights into real-world health solutions, emphasizing interdisciplinary collaboration, standardized reporting, and evidence-based policymaking.

Indexed as

causal-MLeconometric methodsexplainable artificial intelligence AIhuman microbiomepolicy translation

Identifiers

PMID41103759
PMCPMC12521120

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.